Chapter 1 Rhodopsin‐Mediated Retinitis Pigmentosa
Authors:
- 1 January 2009
- book chapter
- Published by Elsevier
- Vol. 88, 1-31
Abstract
No abstract availableKeywords
This publication has 66 references indexed in Scilit:
- Improved Retinal Function in a Mouse Model of Dominant Retinitis Pigmentosa Following AAV-delivered Gene TherapyMolecular Therapy, 2009
- Stimulation of the insulin/mTOR pathway delays cone death in a mouse model of retinitis pigmentosaNature Neuroscience, 2008
- Polyglutamine neurodegeneration: protein misfolding revisitedTrends in Neurosciences, 2008
- 11-cis- and All-trans-Retinols Can Activate Rod Opsin: Rational Design of the Visual CycleBiochemistry, 2008
- A Novel Form of Transducin-Dependent Retinal Degeneration: Accelerated Retinal Degeneration in the Absence of Rod TransducinInvestigative Ophthalmology & Visual Science, 2007
- RNA Interference–Mediated Suppression and Replacement of Human Rhodopsin In VivoThe American Journal of Human Genetics, 2007
- Rod-derived Cone Viability Factor-2 is a novel bifunctional-thioredoxin-like protein with therapeutic potentialBMC Molecular Biology, 2007
- Retinal Stem Cells Transplanted into Models of Late Stages of Retinitis Pigmentosa Preferentially Adopt a Glial or a Retinal Ganglion Cell FateInvestigative Ophthalmology & Visual Science, 2007
- Retinal repair by transplantation of photoreceptor precursorsNature, 2006
- Antioxidants reduce cone cell death in a model of retinitis pigmentosaProceedings of the National Academy of Sciences, 2006